Determination of Utility of Intergluteal Cleft as Landmark for Neuraxial Midline in Obstetrics
NCT ID: NCT05983029
Last Updated: 2024-02-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
99 participants
OBSERVATIONAL
2023-12-07
2024-09-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Prenatal and Postnatal Ultrasonographic Evaluation of Myelomeningocele to Predict Post-Surgical Outcomes
NCT07048691
The Role of Ultrasonography in Labor in Predicting the Outcomes of Childbirth
NCT06806904
Prediction of Delivery Mode by Ultrasound-assessed Fetal Position in Nulliparous Women With Prolonged First Stage of Labor.
NCT05206409
Nuchal Cord Detection in Sonographic Evaluation by a First Year Resident.
NCT03100929
Perinatal Outcomes in Umbilical Cord Entanglement
NCT03504969
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Difference in horizontal distance between the vertical lines of the intergluteal cleft and the neuraxial midline, the latter measured with ultrasound
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CROSSOVER
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Study Group
Each patient will be requested to adopt a standardised upright position. First, two of the investigators will use a spirit level ruler and ink pen to agree upon and visibly mark the horizontal intercristal line on the back of the patient. Second, investigator B will leave the room, and investigator A will make a vertical mark with an ultraviolet pen denoting the intersection of the inferior aspect of the intergluteal cleft and the horizontal intercristal line. Third, investigator A will then leave the room, and investigator B will return to the room to make a vertical mark with an ink pen representing the intersection of the neuraxial midline, as established with the transverse spinous process view on ultrasound, and the horizontal intercristal line. After these two vertical marks have been made at the level of the intercristal line, the horizontal distance between them will be measured in mm by these same two investigators
Intergluteal Cleft
Marking of intersection between inferior aspect of the intergluteal cleft and the horizontal intercristal line
Neuraxial Midline
Marking of intersection between the neuraxial midline, as established with the transverse spinous process view on ultrasound, and the horizontal intercristal line
Horizontal Distance between Vertical Markings
The horizontal distance between these two vertical marks will be measured at the level of the intercristal line
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Intergluteal Cleft
Marking of intersection between inferior aspect of the intergluteal cleft and the horizontal intercristal line
Neuraxial Midline
Marking of intersection between the neuraxial midline, as established with the transverse spinous process view on ultrasound, and the horizontal intercristal line
Horizontal Distance between Vertical Markings
The horizontal distance between these two vertical marks will be measured at the level of the intercristal line
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* 18 years of age or older
* Gestation of 37 weeks or above
Exclusion Criteria
* Allergy to ultrasound gel
* Positive for COVID-19 and/or presence of symptoms consistent with SARS-Cov-2, such as anosmia, cough or fever
* History of previous surgery to the spine
* Scoliosis
* Unable to speak and/or understand English
18 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Guy's and St Thomas' NHS Foundation Trust
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Gill Arbane, BSc
Role: STUDY_CHAIR
Guys' & St Thomas' NHS Foundation Trust
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Guy's Hospital, Great Maze Pond
London, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
291462
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.